Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (909)	5/29/2008 8:47:09 AM
From: rkrw	Read Replies (1) \| Respond to of 933

Interesting since Bristol had dumped their epothilone jv agreement last year! Unbelievable premium, wish I owned some. Sigh. That could really shake up the charity contest!

To: scaram(o)uche who wrote (909)	5/29/2008 9:59:39 AM
From: kenhott	Read Replies (2) \| Respond to of 933

Me no own any either. Who is next? This ain't stopping soon. The need is there, the money is there and the valuations are good for targets. People use to say you don't get double BIG permium buyouts. Not true anymore. This market has driven a lot of people down on the bios. Tough market, tough FDA, tough conditions in general. Hope everyone else owns a bunch of KOSN. We could all use a refreshing breath of something good.